1.
JOP
; 9(5): 588-92, 2008 Sep 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18762689
Assuntos
Pancreatite Crônica/etiologia , Consumo de Bebidas Alcoólicas/tendências , Doenças Autoimunes/complicações , Predisposição Genética para Doença , Geografia , Humanos , Estilo de Vida , Pancreatite Alcoólica/epidemiologia , Pancreatite Crônica/epidemiologia , Fatores de Risco , Fatores Socioeconômicos
2.
IDrugs
; 7(2): 160-5, 2004 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15057661
RESUMO
Acute colonic pseudo-obstruction (Ogilvie's syndrome) is characterized by an acute obstruction of the large bowel that is unrelated to mechanical causes. The evidence that cholinesterase inhibitors are effective in relieving acute colonic pseudo-obstruction raised interest in the pharmacological management of this condition. This review analyzes the pharmacological treatment of patients with Ogilvie's syndrome. Intravenous neostigmine is the best pharmacological treatment, leading to rapid colonic decompression. New colokinetic agents, including 5-HT(4) receptor agonists and motilides, may represent other useful therapeutic options for Ogilvie's syndrome.